3-phenyllactic acid

Show results for

Metabolomics (91)
Unknown (55)
Genomics (5)
Proteomics (2)
Transcriptomics (1)

Organisms

Mus musculus (1)
Lepeophtheirus salmonis (1)
Caulobacter sp. S3H41 (1)
Mycoplasma sp. enrichment culture (1)
Kayvirus kay (1)
Pseudoalteromonas sp. Bsw20308 (1)
Rauvolfia tetraphylla (1)
Oxalobacter formigenes (1)
Pyropia yezoensis (1)
Proboscidea (1)
Hippophae rhamnoides subsp. mongolica (1)
Mariprofundus ferrooxydans PV-1 (1)
Mycobacterium tuberculosis C (1)
Bjerkandera adusta (1)
Methanococcus voltae A3 (1)
Streptococcus agalactiae serogroup V (1)
Allobaculum sp. (1)
Aspergillus parasiticus (1)
Pseudomonas sp. rDWA119 (1)
Rasamsonia emersonii (1)
Dracocephalum grandiflorum (1)
Bovine rotavirus strain RF (1)
Phaeocystis globosa virus 14T (1)
Phaeocystis globosa virus (1)
Lacticaseibacillus (1)
Collimonas pratensis (1)
Petromyzon marinus (1)
Xiphophorus malinche x Xiphophorus birchmanni (1)
Preplasmiviricota sp. Gezel-14T (1)
Lactiplantibacillus (1)

Organisms

metagenome (1)
food fermentation metagenome (1)
Mus musculus (1)

Repository

MetabolomicsWorkbench (86)
MetaboLights (5)
ENA (5)
geo (1)
MassIVE (1)
pride (1)

Tissue

Blood (28)
Feces (12)
Bacterial cells (8)
Cultured cells (7)
Intestine (4)
Heart (3)
Kidney (3)
Urine (3)
Biofilm (2)
Tail (2)
Stem cells (2)
Cecum (2)
Subcutaneous fat (1)
Hepatopancreas (1)
Food (1)
Ventricles (1)
Parasite (1)
Plasmodium cells (1)
Cardiomyocyte cells (1)
Tissue (1)
Saliva (1)
Cells (1)
Bone marrow (1)
Plant (1)
Lung (1)
Jejunum (1)
Tumor cells (1)
Muscle (1)
Cerebrospinal fluid (1)
Liver (1)

Disease

Cancer (10)
Malaria (4)
Diabetes (3)
Ulcerative colitis (2)
Myalgic encephalomyelitis/chronic fatigue syndrome (2)
NASH (2)
Inflammation (2)
Endotoxemia (1)
Cardiomyopathy (1)
Infection (1)
Autism (1)
Angina (1)
Irritable bowel syndrome (1)
HIV (1)
Heart disease (1)
Tuberculosis (1)
Antibiotic resistance (1)
Obesity (1)
Kidney disease (1)
COVID-19 (1)
Skin melanoma (1)

Technology Type

Mass Spectrometry (87)
ESI (65)
EI (23)
Mass spectrometry (4)
Mass spectrometry assay (1)
API (1)
Data-independent acquisition (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Thermo Trace 1310 GC-MS with ISQ LT (single quadrupole) (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - hilic (1)

CHEBI ID

CHEBI:16709 (3)
CHEBI:15741 (3)
CHEBI:7916 (3)
CHEBI:18183 (3)
CHEBI:16411 (3)
CHEBI:50211 (2)
CHEBI:50392 (2)
CHEBI:2877 (2)
CHEBI:28792 (2)
CHEBI:16356 (2)
CHEBI:16422 (2)
CHEBI:15901 (2)
CHEBI:30805 (2)
CHEBI:28635 (2)
CHEBI:16552 (2)
CHEBI:32797 (2)
CHEBI:166830 (2)
CHEBI:16927 (2)
CHEBI:36313 (2)
CHEBI:18323 (2)
CHEBI:15698 (2)
CHEBI:30849 (2)
CHEBI:9300 (2)
CHEBI:16708 (2)
CHEBI:15956 (2)
CHEBI:506227 (2)
CHEBI:17562 (2)
CHEBI:27470 (2)
CHEBI:15746 (2)
CHEBI:30832 (2)

Metabolite Name

Retinol (2)
N-Acetyl-L-aspartic acid (2)
Homovanillic acid (2)
Uracil (2)
Thymine (2)
Hydroxyphenyllactic acid (2)
Maleic acid (2)
Pantothenic acid (2)
N-Acetylneuraminic acid (2)
Suberic acid (2)
Riboflavin (2)
Porphobilinogen (2)
L-Tryptophan (2)
Glutaric acid (2)
Dodecanoic acid (2)
Azelaic acid (2)
Adipic acid (2)
Cytidine (2)
Inosine (2)
Anhalamine (1)
Antiarol (1)
4-Chloro-17alpha-methyl-17beta-hydroxy-4-androsten-3-one (1)
Coleonol (1)
Erythro-3-Hydroxy-Ls-aspartate (1)
Hydroxyindole (1)
Enterostatin (1)
Estriol 16alpha-(beta-D-glucuronide) (1)
1,3,5(10)-Estratrien-3,17beta-diol 17-glucosiduronate (1)
Beta-Estradiol 3-sulfate (1)
Ribavirin (1)

First Public Date

2026 (4)
2025 (1)

Release Date

2025 (11)
2022 (10)
2023 (8)
2021 (8)
2024 (7)
2020 (3)
2018 (3)
2016 (2)
2015 (1)
2014 (1)
2011 (1)

Lab affiliation

The School of Public Health and Medical Technology, Xiamen Medical College, Xiamen 361023, China (1)

Publication date

2025 (3)
2026 (2)
2023 (2)
2020 (1)

Previous page
1 / 16
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 16
Next page

Sort by:

Relevance

Page size

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer (Targeted organic acid assay)

BACKGROUND: Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are current clinical challenges.

METHODS: The serum metabolites of 20 healthy individuals and patients with prostat...

2023-04-17 | MTBLS6038 | MetaboLights

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer (Untargeted assay)

BACKGROUND: Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges.

METHODS: The serum metabolites of 20 healthy individuals and patients with prosta...

2023-04-17 | MTBLS6039 | MetaboLights

Proteomics of B16-F10 cells treated by carboxylic acids

To elucidate the mechanisms by which the four carboxylic acids—3-phenyllactic acid, lactic acid, L-pyroglutamic acid, and malic acid—inhibit melanin production in B16-F10 cells, a comparative proteomic analysis was conducted to assess changes in protein expression.

ORGANISM(S): Mus musculus (Mouse)

2025-05-07 | PXD061919 | Pride